Therefore, investigating PGx interactions of novel genes/variants, other than NUDT15 and TPMT variations, is urgently needed for preventing thiopurine intolerance due to hematological toxicities and improving pediatric ALL care. Here, NUDT15 is linked to acute lymphoblastic leukemia.